University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > HIV Meds Updates > ARV Interactions
Updates to the Database of ARV Drug Interactions
gray line
transparent gif
transparent gif

The following table summarizes recent additions to the HIV InSite Database of Antiretroviral Drug Interactions.For a full description of the updates, including references to the studies from which the data were derived, go to the database, click on a specific drug name, and search for the interacting agent.

New ARV Interactions (January-April 2012)
Drug OneDrug TwoClinical EffectsMechanismsManagement
Source: McNicholl I. HIV InSite Database of Antiretroviral Drug Interactions. University of California San Francisco: Center for HIV Information; 2012.
AtazanavirBoceprevirDecreased HIV treatment efficacyDo not coadminister
DarunavirBoceprevirDecreased HIV and HCV treatment efficacyDo not coadminister
DarunavirBeclomethasoneNo dosage adjustment necessary
DarunavirPravastatinNo dosage adjustment necessary
Lopinavir/ritonavirBoceprevirDecreased HIV and HCV treatment efficacyDo not coadminister
NevirapineLumefantrinePotentially increased treatment failureDo not coadminister; avoid arthemether/lumefantrine in patients receiving nevirapine if at all possible
NevirapineArtemetherPotentially increased treatment failureDo not coadminister; avoid arthemether/lumefantrine in patients receiving nevirapine if at all possible
RaltegravirBoceprevirNo dosage adjustment necessary
RaltegravirRilpivirineNo dosage adjustment necessary
RaltegravirRifapentineDosage adjustment not established
RitonavirBeclomethasoneUse lowest possible dosage and titrate to effect

transparent gif